Use of vascular access for haemodialysis in Europe: a report from the ERA-EDTA Registry

Marlies Noordzij; Kitty J. Jager; Sabine N. van der Veer; Reinhard Kramar; Frederic Collart; James G. Heaf; Olivera Stojceva-Taneva; Torbjørn Leivestad; Jadranka Buturovic-Ponikvar; Manuel Benítez Sánchez; Fransesc Moreso; Karl G. Prütz; Alison Severn; Christoph Wanner; Raymond Vanholder; Pietro Ravani

doi:10.1093/ndt/gfu253

Use of vascular access for haemodialysis in Europe: a report from the ERA-EDTA Registry

Marlies Noordzij (Lead / Corresponding author), Kitty J. Jager, Sabine N. van der Veer, Reinhard Kramar, Frederic Collart, James G. Heaf, Olivera Stojceva-Taneva, Torbjørn Leivestad, Jadranka Buturovic-Ponikvar, Manuel Benítez Sánchez, Fransesc Moreso, Karl G. Prütz, Alison Severn, Christoph Wanner, Raymond Vanholder, Pietro Ravani

Research output: Contribution to journal › Article › peer-review

79 Citations (Scopus)

Abstract

Background Although arteriovenous fistulas (AVFs) are actively promoted, their use at the start of haemodialysis (HD) seems to be decreasing worldwide. In this paper, we describe recent trends in incidence and prevalence of vascular access types in Europe from 2005 to 2009 and their relationship with patient characteristics and survival.

Methods Ten European renal registries participating in the ERA-EDTA Registry provided data on incidence (n = 13 044) and/or prevalence (n = 75 715) of vascular access types. We used logistic regression to assess which factors influence the likelihood to be treated with an AVF rather than another type.

Results The use of AVFs at the start of HD showed a significant decreasing trend from 42% in 2005 to 32% in 2009 (P < 0.0001), while the use of central venous catheters (CVCs) increased from 58 to 68% (P < 0.0001). A similar evolution pattern was observed for the prevalence; use of AVFs decreased from 66 to 62% and use of CVCs increased from 28 to 32%. There was a large international variation in the use of the different vascular access types. Female patients [adjusted odds ratio: 0.84, 95% confidence interval (CI): 0.78–0.90] and those =80 years (0.77, 95% CI: 0.67–0.90) were least likely to start HD with an AVF.

Conclusion In Europe, there is a decreasing trend in the use of AVFs and an increasing trend in the use of CVCs at the start and after the start of HD. We cannot explain all between-country variations we found, and more research is needed to clarify how healthcare around vascular access is organized in Europe.

Original language	English
Pages (from-to)	1956-1964
Number of pages	9
Journal	Nephrology Dialysis Transplantation
Volume	29
Issue number	10
DOIs	https://doi.org/10.1093/ndt/gfu253
Publication status	Published - Oct 2014

Access to Document

10.1093/ndt/gfu253

http://ndt.oxfordjournals.org/

Cite this

Noordzij, M., Jager, K. J., van der Veer, S. N., Kramar, R., Collart, F., Heaf, J. G., Stojceva-Taneva, O., Leivestad, T., Buturovic-Ponikvar, J., Benítez Sánchez, M., Moreso, F., Prütz, K. G., Severn, A., Wanner, C., Vanholder, R., & Ravani, P. (2014). Use of vascular access for haemodialysis in Europe: a report from the ERA-EDTA Registry. Nephrology Dialysis Transplantation, 29(10), 1956-1964. https://doi.org/10.1093/ndt/gfu253

@article{848ed05ecb3c47278799d47c42246667,

title = "Use of vascular access for haemodialysis in Europe: a report from the ERA-EDTA Registry",

abstract = "Background Although arteriovenous fistulas (AVFs) are actively promoted, their use at the start of haemodialysis (HD) seems to be decreasing worldwide. In this paper, we describe recent trends in incidence and prevalence of vascular access types in Europe from 2005 to 2009 and their relationship with patient characteristics and survival.Methods Ten European renal registries participating in the ERA-EDTA Registry provided data on incidence (n = 13 044) and/or prevalence (n = 75 715) of vascular access types. We used logistic regression to assess which factors influence the likelihood to be treated with an AVF rather than another type.Results The use of AVFs at the start of HD showed a significant decreasing trend from 42% in 2005 to 32% in 2009 (P < 0.0001), while the use of central venous catheters (CVCs) increased from 58 to 68% (P < 0.0001). A similar evolution pattern was observed for the prevalence; use of AVFs decreased from 66 to 62% and use of CVCs increased from 28 to 32%. There was a large international variation in the use of the different vascular access types. Female patients [adjusted odds ratio: 0.84, 95% confidence interval (CI): 0.78–0.90] and those =80 years (0.77, 95% CI: 0.67–0.90) were least likely to start HD with an AVF.Conclusion In Europe, there is a decreasing trend in the use of AVFs and an increasing trend in the use of CVCs at the start and after the start of HD. We cannot explain all between-country variations we found, and more research is needed to clarify how healthcare around vascular access is organized in Europe.",

author = "Marlies Noordzij and Jager, {Kitty J.} and {van der Veer}, {Sabine N.} and Reinhard Kramar and Frederic Collart and Heaf, {James G.} and Olivera Stojceva-Taneva and Torbj{\o}rn Leivestad and Jadranka Buturovic-Ponikvar and {Ben{\'i}tez S{\'a}nchez}, Manuel and Fransesc Moreso and Pr{\"u}tz, {Karl G.} and Alison Severn and Christoph Wanner and Raymond Vanholder and Pietro Ravani",

year = "2014",

month = oct,

doi = "10.1093/ndt/gfu253",

language = "English",

volume = "29",

pages = "1956--1964",

journal = "Nephrology Dialysis Transplantation",

issn = "1460-2385",

publisher = "Oxford University Press",

number = "10",

}

Noordzij, M, Jager, KJ, van der Veer, SN, Kramar, R, Collart, F, Heaf, JG, Stojceva-Taneva, O, Leivestad, T, Buturovic-Ponikvar, J, Benítez Sánchez, M, Moreso, F, Prütz, KG, Severn, A, Wanner, C, Vanholder, R & Ravani, P 2014, 'Use of vascular access for haemodialysis in Europe: a report from the ERA-EDTA Registry', Nephrology Dialysis Transplantation, vol. 29, no. 10, pp. 1956-1964. https://doi.org/10.1093/ndt/gfu253

TY - JOUR

T1 - Use of vascular access for haemodialysis in Europe

T2 - a report from the ERA-EDTA Registry

AU - Noordzij, Marlies

AU - Jager, Kitty J.

AU - van der Veer, Sabine N.

AU - Kramar, Reinhard

AU - Collart, Frederic

AU - Heaf, James G.

AU - Stojceva-Taneva, Olivera

AU - Leivestad, Torbjørn

AU - Buturovic-Ponikvar, Jadranka

AU - Benítez Sánchez, Manuel

AU - Moreso, Fransesc

AU - Prütz, Karl G.

AU - Severn, Alison

AU - Wanner, Christoph

AU - Vanholder, Raymond

AU - Ravani, Pietro

PY - 2014/10

Y1 - 2014/10

N2 - Background Although arteriovenous fistulas (AVFs) are actively promoted, their use at the start of haemodialysis (HD) seems to be decreasing worldwide. In this paper, we describe recent trends in incidence and prevalence of vascular access types in Europe from 2005 to 2009 and their relationship with patient characteristics and survival.Methods Ten European renal registries participating in the ERA-EDTA Registry provided data on incidence (n = 13 044) and/or prevalence (n = 75 715) of vascular access types. We used logistic regression to assess which factors influence the likelihood to be treated with an AVF rather than another type.Results The use of AVFs at the start of HD showed a significant decreasing trend from 42% in 2005 to 32% in 2009 (P < 0.0001), while the use of central venous catheters (CVCs) increased from 58 to 68% (P < 0.0001). A similar evolution pattern was observed for the prevalence; use of AVFs decreased from 66 to 62% and use of CVCs increased from 28 to 32%. There was a large international variation in the use of the different vascular access types. Female patients [adjusted odds ratio: 0.84, 95% confidence interval (CI): 0.78–0.90] and those =80 years (0.77, 95% CI: 0.67–0.90) were least likely to start HD with an AVF.Conclusion In Europe, there is a decreasing trend in the use of AVFs and an increasing trend in the use of CVCs at the start and after the start of HD. We cannot explain all between-country variations we found, and more research is needed to clarify how healthcare around vascular access is organized in Europe.

AB - Background Although arteriovenous fistulas (AVFs) are actively promoted, their use at the start of haemodialysis (HD) seems to be decreasing worldwide. In this paper, we describe recent trends in incidence and prevalence of vascular access types in Europe from 2005 to 2009 and their relationship with patient characteristics and survival.Methods Ten European renal registries participating in the ERA-EDTA Registry provided data on incidence (n = 13 044) and/or prevalence (n = 75 715) of vascular access types. We used logistic regression to assess which factors influence the likelihood to be treated with an AVF rather than another type.Results The use of AVFs at the start of HD showed a significant decreasing trend from 42% in 2005 to 32% in 2009 (P < 0.0001), while the use of central venous catheters (CVCs) increased from 58 to 68% (P < 0.0001). A similar evolution pattern was observed for the prevalence; use of AVFs decreased from 66 to 62% and use of CVCs increased from 28 to 32%. There was a large international variation in the use of the different vascular access types. Female patients [adjusted odds ratio: 0.84, 95% confidence interval (CI): 0.78–0.90] and those =80 years (0.77, 95% CI: 0.67–0.90) were least likely to start HD with an AVF.Conclusion In Europe, there is a decreasing trend in the use of AVFs and an increasing trend in the use of CVCs at the start and after the start of HD. We cannot explain all between-country variations we found, and more research is needed to clarify how healthcare around vascular access is organized in Europe.

U2 - 10.1093/ndt/gfu253

DO - 10.1093/ndt/gfu253

M3 - Article

C2 - 25061126

SN - 1460-2385

VL - 29

SP - 1956

EP - 1964

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

IS - 10

ER -

Use of vascular access for haemodialysis in Europe: a report from the ERA-EDTA Registry

Abstract

Access to Document

Fingerprint

Cite this